167 related articles for article (PubMed ID: 36672150)
1. The Fibrotic Effects of LINC00663 in Human Hepatic Stellate LX-2 Cells and in Bile Duct-Ligated Cholestasis Mice Are Mediated through the Splicing Factor 2-Fibronectin.
Chu Y; Bao L; Teng Y; Yuan B; Ma L; Liu Y; Kang H
Cells; 2023 Jan; 12(2):. PubMed ID: 36672150
[TBL] [Abstract][Full Text] [Related]
2. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
3. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.
Kennedy LL; Meng F; Venter JK; Zhou T; Karstens WA; Hargrove LA; Wu N; Kyritsi K; Greene J; Invernizzi P; Bernuzzi F; Glaser SS; Francis HL; Alpini G
Lab Invest; 2016 Dec; 96(12):1256-1267. PubMed ID: 27775690
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases.
Yang YL; Wang FS; Li SC; Tiao MM; Huang YH
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells improve liver fibrosis and protect hepatocytes by promoting microRNA-148a-5p-mediated inhibition of Notch signaling pathway.
Zhou Q; Rong C; Gu T; Li H; Wu L; Zhuansun X; Zhao X; Xiao Z; Kuang Y; Xu S; Wang S
Stem Cell Res Ther; 2022 Jul; 13(1):354. PubMed ID: 35883205
[TBL] [Abstract][Full Text] [Related]
6. LncRNA-ATB/microRNA-200a/β-catenin regulatory axis involved in the progression of HCV-related hepatic fibrosis.
Fu N; Zhao SX; Kong LB; Du JH; Ren WG; Han F; Zhang QS; Li WC; Cui P; Wang RQ; Zhang YG; Nan YM
Gene; 2017 Jun; 618():1-7. PubMed ID: 28302418
[TBL] [Abstract][Full Text] [Related]
7. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of S100B and RAGE in a Mouse Model of Bile Duct Ligation-induced Liver Fibrosis.
Park JW; Kim MJ; Kim SE; Kim HJ; Jeon YC; Shin HY; Park SJ; Jang MK; Kim DJ; Park CK; Choi EK
J Korean Med Sci; 2021 Apr; 36(14):e90. PubMed ID: 33847081
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
[TBL] [Abstract][Full Text] [Related]
10. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
[TBL] [Abstract][Full Text] [Related]
12. Foxf1 siRNA delivery to hepatic stellate cells by DBTC lipoplex formulations ameliorates fibrosis in livers of bile duct ligated mice.
Abshagen K; Brensel M; Genz B; Roth K; Thomas M; Fehring V; Schaeper U; Vollmar B
Curr Gene Ther; 2015; 15(3):215-27. PubMed ID: 25619889
[TBL] [Abstract][Full Text] [Related]
13. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation.
Lu ZN; Niu WX; Zhang N; Ge MX; Bao YY; Ren Y; Guo XL; He HW
Acta Pharmacol Sin; 2021 Nov; 42(11):1808-1820. PubMed ID: 34465912
[TBL] [Abstract][Full Text] [Related]
14. Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats.
McMillin M; DeMorrow S; Glaser S; Venter J; Kyritsi K; Zhou T; Grant S; Giang T; Greene JF; Wu N; Jefferson B; Meng F; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G410-G418. PubMed ID: 28751425
[TBL] [Abstract][Full Text] [Related]
15. miR-345-5p curbs hepatic stellate cell activation and liver fibrosis progression by suppressing hypoxia-inducible factor-1alpha expression.
Wang P; Fang Y; Qiu J; Zhou Y; Wang Z; Jiang C
Toxicol Lett; 2022 Nov; 370():42-52. PubMed ID: 36126797
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
[TBL] [Abstract][Full Text] [Related]
17. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4.
Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS
PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation.
Huang YH; Kuo HC; Yang YL; Wang FS
Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific deletion of microRNA-34a alleviates ductular reaction and liver fibrosis during experimental cholestasis.
Wan Y; Zhou T; Slevin E; Koyama S; Li X; Harrison K; Li T; Zhou B; Lorenzo SR; Zhang Y; Xu W; Klaunig JE; Wu C; Shetty AK; Huang CK; Meng F
FASEB J; 2023 Feb; 37(2):e22731. PubMed ID: 36583714
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
Olsen AL; Sackey BK; Marcinkiewicz C; Boettiger D; Wells RG
Gastroenterology; 2012 Apr; 142(4):928-937.e3. PubMed ID: 22202457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
